Frank Xing, | |
9940 Talbert Ave Ste 100, Fountain Valley, CA 92708-5153 | |
(714) 378-5062 | |
Not Available |
Full Name | Frank Xing |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 10 Years |
Location | 9940 Talbert Ave Ste 100, Fountain Valley, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750792545 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | A169497 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorialcare Orange Coast Medical Center | Fountain valley, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Truong Neuroscience Institute Inc. | 6002058633 | 6 |
News Archive
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
Once viewed as an "outlandish morally objectionable" concept with science-fiction overtones, face transplantation is now accepted as a "feasible and necessary treatment" for severely disfigured patients.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which currently cares for over 49,000 AIDS patients in Uganda through its Uganda CARES network of eleven treatment clinics throughout the country, today lauded the United States government for increasing its funding commitment in Uganda for the President's Emergency Plan for AIDS Relief (PEPFAR), the United States' respected global AIDS program.
Scientists from Jerusalem and Duesseldorf have succeeded in generating induced pluripotent stem cells from a rare disorder called Nijmegen breakage syndrome (NBS) and to push these cells to become early neurons, revealing the mechanisms leading to the neurological phenotype observed in these patients.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.
› Verified 3 days ago
Entity Name | Truong Neuroscience Institute Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952643512 PECOS PAC ID: 6002058633 Enrollment ID: O20130812000552 |
News Archive
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
Once viewed as an "outlandish morally objectionable" concept with science-fiction overtones, face transplantation is now accepted as a "feasible and necessary treatment" for severely disfigured patients.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which currently cares for over 49,000 AIDS patients in Uganda through its Uganda CARES network of eleven treatment clinics throughout the country, today lauded the United States government for increasing its funding commitment in Uganda for the President's Emergency Plan for AIDS Relief (PEPFAR), the United States' respected global AIDS program.
Scientists from Jerusalem and Duesseldorf have succeeded in generating induced pluripotent stem cells from a rare disorder called Nijmegen breakage syndrome (NBS) and to push these cells to become early neurons, revealing the mechanisms leading to the neurological phenotype observed in these patients.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Frank Xing, 9940 Talbert Ave Ste 100, Fountain Valley, CA 92708-5153 Ph: (714) 378-5635 | Frank Xing, 9940 Talbert Ave Ste 100, Fountain Valley, CA 92708-5153 Ph: (714) 378-5062 |
News Archive
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
Once viewed as an "outlandish morally objectionable" concept with science-fiction overtones, face transplantation is now accepted as a "feasible and necessary treatment" for severely disfigured patients.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which currently cares for over 49,000 AIDS patients in Uganda through its Uganda CARES network of eleven treatment clinics throughout the country, today lauded the United States government for increasing its funding commitment in Uganda for the President's Emergency Plan for AIDS Relief (PEPFAR), the United States' respected global AIDS program.
Scientists from Jerusalem and Duesseldorf have succeeded in generating induced pluripotent stem cells from a rare disorder called Nijmegen breakage syndrome (NBS) and to push these cells to become early neurons, revealing the mechanisms leading to the neurological phenotype observed in these patients.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.
› Verified 3 days ago
Kong Truong, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9940 Talbert Ave, Suite 204, Fountain Valley, CA 92708 Phone: 714-378-5635 | |
Dr. William Mac Young, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11770 Warner Ave, Suite 226, Fountain Valley, CA 92708 Phone: 714-241-8560 Fax: 714-241-8576 | |
Dr. Renuka Narain Patel, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18837 Brookhurst St Ste 110, Fountain Valley, CA 92708 Phone: 314-246-0394 | |
Mohammad Reza Hajighasemi-ossareh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17360 Brookhurst Street, Fountain Valley, CA 92708 Phone: 877-844-0012 Fax: 714-665-4680 | |
Dr. Mimi Shishou Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17360 Brookhurst Street, Fountain Valley, CA 92708 Phone: 877-844-0012 Fax: 714-665-4680 | |
Dr. Craig A Ross, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 16480 Harbor Blvd, Suite 104, Fountain Valley, CA 92708 Phone: 714-775-0777 Fax: 714-775-1026 | |
Dr. Diane Barbara Harris, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 11770 Warner Avenue, Suite 127, Fountain Valley, CA 92708 Phone: 714-967-0660 |